Palmer Luckey has raised $200 million with a biotech partner to genetically engineer war dogs and cut U.S. reliance on European breeders.
Dangerous Minds reported that the Anduril founder is teaming with Ben Lamm of Colossal Biosciences to launch Warhound, a startup built to genetically engineer and clone dogs for war, police work, and first-responder missions.
The company has already raised $200 million. Anduril is slated to supply armor and battlefield tech. Colossal is tasked with the genetics and cloning. The first wave of puppies is speculated for early 2027.
The pitch is blunt. America’s military working dogs mostly come from overseas. Warhound wants to fix that at home, with healthier animals and modern gear strapped to the job.
Warhound’s plan starts with DNA collected from proven working breeds, Belgian Malinois, some Labradors, and some shepherds used by the military, police, and first responders.
Colossal’s side of the work is to engineer that DNA to strip out common health problems, including hip dysplasia and certain cancers, then clone and produce the dogs. The company markets itself as a “de-extinction” firm and has said it already genetically engineered the births of three direwolves, a predator extinct for about 10,000 years.
Anduril, Luckey’s defense technology company focused on autonomous military hardware, is expected to outfit the animals. That means bulletproof vests, visors, body armor, and a link into Anduril’s Eagle Eye system so the dogs can work alongside handlers and machines.
Lamm described the project to Wired as twofold, genetics on one track, battlefield technology on the other. He later put the integration goal in plain terms to Fortune.
Lamm told Fortune:
"dogs, handlers, and autonomous systems operate as one team."
Luckey framed the company’s aim in a Warhound press release.
"Man’s best friend deserves man’s best tech."
The strategic hook is supply. A social post by Jesse Tinsley on X, dated October 23, 2026, and cited in the same coverage, said Warhound launched with $200 million in funding at a $1.2 billion valuation and noted that more than 80% of America’s military working dogs are imported from Europe.
That import dependence is the problem Warhound is selling itself as the answer to. Train the animals for bomb detection and search-and-rescue. Breed and build them in a system designed for U.S. needs rather than European kennel capacity. Pair the dog with armor and a sensor network instead of sending a handler out with yesterday’s kit.
No headquarters city, lab site, or training base was named in the initial report. No government contract, procurement order, or regulatory approval was listed either. The public case so far rests on the funding, the two companies’ stated roles, the breed DNA already collected, and the early-2027 puppy timeline offered as speculation.
Luckey’s Anduril has spent years pushing autonomous systems into military use. Lamm’s Colossal has chased high-profile genetic projects, including the direwolf claim. Warhound sits at the overlap: take working-dog bloodlines, edit out known failure points, clone at scale, and wire the result into a modern tactical stack.
For bomb techs, border teams, and disaster crews, a dog that lasts longer, breaks down less, and shares data with the rest of the unit is a logistics argument as much as a science story. The United States has long bought that capability from European breeders. This venture says it can grow it here.
Whether the first litter lands on schedule in early 2027 will be the first hard test. Until then, the record shows a funded startup, two specialized parent companies, a clear import problem, and a public promise to put better tools on four legs.
When the country still ships in most of its military dogs, building a stronger American K9 pipeline is not science fiction, it is overdue common sense.
